3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Completed
2
Terminated
1
Recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Breast Neoplasms
5
Small Cell Lung Carcinoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Gallbladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Glioma
2
Cholangiocarcinoma
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
TNBC
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Intraepithelial Lesions
1
Smoldering Multiple Myeloma
1
Recurrence
1
Parkinsonian Disorders
1
Pancreatic Neoplasms
1
Pancreatic Cancer Non-resectable
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Interventions
Alginates
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Enrolling by invitation
×
Esophagitis
×
Clear all
NCT06958445
2025-05-06
SAFE
Taipei City Hospital
Phase 2
Enrolling by invitation
90 enrolled